SEC Company Response from Envoy Medical, (COCH) — Feb 9, 2026
Envoy Medical, Inc.
Date: Feb. 9, 2026 · CIK: 0001840877 · Accession: 0001213900-26-013896
AI Filing Summary & Sentiment
File numbers found in text: 333-292260
Show Raw Text
CORRESP
1
filename1.htm
February 9, 2026
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street NE
Washington, D.C. 20549
Re:
Envoy Medical, Inc.
Registration Statement on Form S-1, as amended
File No. 333-292260
Ladies and Gentlemen:
In accordance with Rule 461
under the Securities Act of 1933, as amended (the "Securities Act"), H.C. Wainwright & Co., LLC ("Wainwright"),
as placement agent on a best-efforts basis, hereby joins Envoy Medical, Inc. in requesting that the Securities and Exchange Commission
take appropriate action to cause the Registration Statement on Form S-1, as amended (File No. 333-292260) (the "Registration Statement"),
to become effective on Tuesday, February 10, 2026, at 5:15 p.m., Eastern Time, or as soon as practicable thereafter. Wainwright affirms
that it is aware of its obligations under the Securities Act as they pertain to the best efforts offering pursuant to the Registration
Statement.
Very truly yours,
H.C. WAINWRIGHT & CO., LLC
By:
/s/ Edward Silvera
Name:
Edward Silvera
Title:
Co-Chief Executive Officer